Tue, November 22, 2022

Thomas Smith Initiated (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-6-on-nov-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Thomas Smith of SVB Leerink, Initiated "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022.

Thomas has made no other calls on TRVI in the last 4 months.



There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Friday, November 11th, 2022